Laboratory services for thyroglobulin and implications for monitoring of differentiated thyroid cancer

Journal of Clinical Pathology

Volumn 62, Issue 5, 2009, Pages 402-406

  Clark, P M ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

CONCENTRATION (PARAMETERS); DECISION MAKING; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; LABORATORY; MONITORING; PHYSICIAN; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SAMPLE; STANDARDIZATION; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; VALIDATION STUDY;

CELL DIFFERENTIATION; HUMANS; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 66349093171     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.058024     Document Type: Review

References (37)

1. Mazzaferri EL. Will highly sensitive thyroglobulin assays change the management of thyroid cancer? Clin Endocrinol (Oxf) 2007;67:321-323
2. Bachelot A, Cailleux AF, Klain M, et al. Relationship between tumour burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 2002;12:707-711
3. Bachelot A, Leboulleuz S, Baudin E, et al. Neck recurrence from thyroid carcinoma. Serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment. Clin Endocrinol (Oxf) 2005;62:376-379
4. Robbins RJ, Srivastava S, Shaha A, et al. Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma. J Clin Endocrinol Metab 2004;89:6010-6016 (Pubitemid 39628408)
5. David A, Blotta A, Rossi R, et al. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma. Thyroid 2005;15:267-273 (Pubitemid 40418694)
6. 131I uptake. Clin Endocrinol (Oxf) 2008;68:108-116
7. Kebebew E, Treseler PA, Ituarte PH, et al. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 2001;25:632-637 (Pubitemid 32441438)
8. Gerenova J, Buysschaert M, de Burbure CY, et al. Prevalence of thyroid cancer in Graves' disease: a retrospective study of a cohort of 103 patients treated surgically. Eur J Intern Med 2003;14:321-325 (Pubitemid 37108727)
9. British Thyroid Association and Royal College of Physicians. Guidelines for the management of thyroid cancer. 2nd edn. 2007. www.british-thyroid- association.org (accessed 6 Feb 2009).
10. Bjerner J, Børmer OP, Nustad K. The war on heterophilic antibody interference. Clin Chem 2005;51:9-10. (Pubitemid 40024005)
11. Kaplan IV, Levinson SS. When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen. Clin Chem 1999;45:616-618 (Pubitemid 29220321)
12. Preissner CM, O'Kane DJ, Singh RJ, et al. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 2003;88:3069-3074 (Pubitemid 36877474)
13. Masart C, Corcuff J-B, Bordenave L. False-positive results corrected by the use of heterophilic antibody-blocking reagent in thyroglobulin immunoassays. Clin Chim Acta 2008;388:211-213 (Pubitemid 350266560)
14. Giovanella L, Ghelfo A. Undetectable serum thyroglobulin due to negative interference of heterophilic antibodies in relapsing thyroid carcinoma. Clin Chem 2007;53:1871-1872 (Pubitemid 47509689)
15. Schneider AB, Pervos R. Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab 1978;47:126-137 (Pubitemid 8371253)
16. Feldt-Rasmussen U, Rasmussen K. Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo. J Endocrinol Invest 1985;8:571-576 (Pubitemid 16135454)
17. Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998;83:1121-1127 (Pubitemid 28496379)
18. Spencer CA, Bergoglio LM, Kazarosyan M, et al. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005;90:5566-5575 (Pubitemid 41415459)
19. Jensen E, Petersen PH, Blaabjerg O, et al. Biological variation of thyroid autoantibodies and thyroglobulin. Clin Chem Lab Med 2007;45:1058-1064 (Pubitemid 47424850)
20. Görges R, Maniecki M, Jentzen W, et al. Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during 3 years after thyroidectomy. Eur J Endocrinol 2005;153:49-55. (Pubitemid 41030515)
21. Chiovato L, Latrofa F, Braverman LE, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003;5:346-351 (Pubitemid 38124590)
22. Dietlein M, Dressler J, Grunwald F, et al. Guideline for in vivo and in vitro procedures for thyroid diseases (version 2). Nuklearmedizin 2003;42:109-115 (Pubitemid 36773326)
23. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-142
24. Demers LM, Spencer CA, eds. Laboratory support for the diagnosis and monitoring of thyroid disease. 2002 National Academy for Clinical Biochemistry. www.nacb.org (accessed 6 Feb 2009).
25. Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803. (Pubitemid 43997716)
26. Phan HTT, Jager PL, Van der Wal JE, et al. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation. Eur J Endocrinol 2008;158:77-83.
27. Persoon ACM, Links TP, Wilde J, et al. Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma. Clin Chem 2006;52:1196-1199 (Pubitemid 43794436)
28. Stockigt JR. Ambiguous thyroglobulin assay results in the follow-up of differentiated thyroid carcinoma [editorial]. J Clin Endocrinol Metab 2005;90:5904-5905 (Pubitemid 41415510)
29. Ismail AAA, Walker P, Barth J, et al. Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem 2002;48:2023-2029 (Pubitemid 35222761)
30. Ross HA, Netea-Maier R, Schakenraad E, et al. Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: an approach to reduce interpretation differences. Clin Chim Acta 2008;394:104-109
31. Spencer CA, LoPresti JS. Technology insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nat Clin Pract Endocrinol Metab 2008;4:223-233
32. Schlumberger M, Hitzel A, Toubert ME, et al. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007;92:2487-2495 (Pubitemid 47037347)
33. Iervasi A, Iervasi G, Ferdeghini M, et al. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer. Clin Endocrinol (Oxf) 2007;67:434-441 (Pubitemid 47283844)
34. Snozek CLH, Chambers EP, Reading CC, et al. Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of thyroid carcinoma nodal metastases. J Clin Endocrinol Metab 2007;92:4278-4281 (Pubitemid 350074743)
35. Boi F, Baghino G, Atzeni F, et al. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fineneedle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. J Clin Endocrinol Metab 2006;91:1364-1369
36. Sturgeon C, Hoffman BR,Chan DW, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines for use of tumor markers in clinical practice: quality requirements Clin Chem 2008;54:e1-e10.
37. Hoofnagle AN, Becker JO, Wener MH, et al. Quantification of thyroglobulin, a lowabundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 2008;54:1796-1804